Aktiviere Job-Benachrichtigungen per E-Mail!
A leading research institute in Mannheim seeks Research Group Leaders to advance studies in AngioCardioScience. Candidates should have a PhD and a strong publication record. Responsibilities include pioneering research, securing funding, and collaboration with a vibrant research community. The role offers an international work environment and various benefits including flexible hours and subsidies.
HI-TAC seeks Research Group Leaders in the field of AngioCardioScience.
The Helmholtz Institute for Translational AngioCardioScience (HI-TAC) is a branch of the Max Delbrück Center on the campus of Heidelberg University. The Max Delbrück Center and the Mannheim and Heidelberg Medical Faculties of the University of Heidelberg jointly founded HI-TAC. HI-TAC will develop a unique systemic approach in the emerging field of cardiovascular communication biology, which is operationally designated as AngioCardioScience. Translational research at HI-TAC aims at developing a new scientific program centered on communication biology and dedicated to understanding cardiovascular functions on a systemic level during homeostasis, aging and pathological conditions. It will exploit its findings in the area of cross-organ interactions for the development of translational applications.
HI-TAC is currently in the build up phase and will provide a modern place for 100 scientists to conduct research and work in Heidelberg and Mannheim. Join our team and build up the HI-TAC together with the Max Delbrück Center and the University of Heidelberg.
The HI-TAC, a branch of the Max Delbrück Center at Heidelberg University, operates in close collaboration with the two Medical Faculties of Heidelberg University, located in Mannheim and Heidelberg. HI-TAC pioneers a systemic and translational approach to cardiovascular communication biology, termed Translational AngioCardioScience. Its research is dedicated to understanding cardiovascular function throughout lifespan and in disease, with a focus on how vascular and cardiac cells interact with each other and other organ systems to maintain homeostasis or cause disease. The ultimate goal of HI-TAC research is to advance early disease detection, prevention, targeted intervention and long-term remission.
As a newly established and evolving institute, HI-TAC offers group leaders a unique opportunity to help shape its scientific vision and foster an interdisciplinary culture. We invite you to become part of this dynamic and growing community at the forefront of AngioCardioScience.
The newly established Helmholtz Institute for Translational AngioCardioScience (HI-TAC) invites applications from outstanding scientists at the stage of establishing their first independent research group. Candidates should have a strong track record in cardiovascular science or closely related fields that advance our understanding of cardiovascular function and disease. Areas of interest include, but are not limited to, metabolic and mechanical signaling, immune interactions with vasculature or myocardium, and inflammatory pathways, cardiovascular malformations, development, regeneration, and ageing. The HI-TAC Group Leaders are expected to conduct pioneering independent research, secure external funding, and collaborate with top researchers and organizations in the field. The selected candidates will become part of a vibrant and collaborative community at Heidelberg University and the Max Delbrück Center.
As part of HI-TAC’s faculty, you will be able to choose a mentor from senior faculty at Heidelberg University and the Max Delbrück Center.
Please get in touch with any questions
Franziska Hasslinger-Pajtler
HI-TAC
f.hasslinger-pajtler@mdc-berlin.de